Increased gastrointestinal permeability in patients with Plasmodium falciparum malaria

Clinical Infectious Diseases

Volumn 24, Issue 3, 1997, Pages 430-435

  Wilairatana, Polrat ^b   Meddings, Jon B ^a   Ho, May ^b   Vannaphan, Suparb ^b   Looareesuwan, Sornchi ^b  

^a UNIVERSITY OF CALGARY   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ARTESUNATE; LACTULOSE; MANNITOL; MEFLOQUINE; SUCROSE;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GASTROINTESTINAL MUCOSA; GASTROINTESTINAL SYMPTOM; HUMAN; INTESTINE MUCOSA PERMEABILITY; INTRAVENOUS DRUG ADMINISTRATION; MALARIA; MALE; ORAL DRUG ADMINISTRATION; PLASMODIUM FALCIPARUM; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0031019945     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinids/24.3.430     Document Type: Article

References (18)

1. Travis S, Menzies I. Intestinal permeability: functional assessment and significance. Clin Sci (Colch) 1992;82:471-88.
2. Sutherland LR, Verhoef M, Wallace JL, Van Rosendaal G, Crutcher R, Meddings JB. A simple, non-invasive marker of gastric damage: sucrose permeability. Lancet 1994;343:998-1000.
3. Strobel S, Brydon WG, Ferguson A. Cellobiose/mannitol sugar permeability test complements biopsy histopathology in clinical investigation of the jejunum. Gut 1984;25:1241-6.
4. Cobden I, Rothwell J, Axon ATR. Intestinal permeability and screening tests for coeliac disease. Gut 1980;21:512-8.
5. Kapembwa MS, Fleming SC, Sewankambo N, et al. Altered small-intestinal permeability associated with diarrhoea in human-immunodeficiency-virus-infected Caucasian and African subjects. Clin Sci (Colch) 1991;81:327-34.
6. Ukabam SO, Cooper BT. Small intestinal permeability to mannitol, lactulose, and polyethylene glycol 400 in celiac disease. Dig Dis Sci 1984;29:809-16.
7. LeVoyer T, Cioffi WG Jr, Pratt L, et al. Alterations in intestinal permeability after thermal injury. Arch Surg 1992;127:26-30.
8. Ziegler TR, Smith RJ, O'Dwyer ST, Demling RH, Wilmore DW. Increased intestinal permeability associated with infection in bum patients. Arch Surg 1988;123:1313-9.
9. World Health Organization. Severe and complicated malaria. Second edition. Trans R Soc Trop Med Hyg 1990;84(suppl 2):1-65.
10. Molyneux ME, Looareesuwan S, Menzies IS, et al. Reduced hepatic blood flow and intestinal malabsorption in severe falciparum malaria. Am J Trop Med Hyg 1989;40:470-6.
11. Looareesuwan S, Viravan C, Vanijanonta S, et al. Randomised trial of artesunate and mefloquine alone and in sequence for acute uncomplicated falciparum malaria. Lancet 1992;339:821-4.
12. Meddings JB, Sutherland LR, Byles NI, Wallace JL. Sucrose: a novel permeability marker for gastroduodenal disease. Gastroenterology 1993;104:1619-26.
13. Boonpucknavig V, Srichaikul T, Punyagupta S. Clinical pathology. In: Peters W, Richards WHG, eds. Handbook of experimental pharmacology, Vol. 68/I. Antimalarial drugs I. Biological background, experimental methods, and drug resistance. Berlin, New York: Springer-Verlag, 1984:127-76.
14. Wilairatana P, Riganti M, Looareesuwan S, Punpoowong B, Srisopark P, Charoenlarp P. Dyspepsia in acute falciparum malaria: a clinico-pathological correlation. Southeast Asian J Trop Med Public Health 1992;23:788-94.
15. Elia M, Northrop-Clewes CA, Lunn PG, Goren A. Intestinal permeability in man: effects of acute systemic infections. Clinical Nutrition 1991;10:76-80.
16. Usawattanakul W, Tharavanij S, Warrell DA, et al. Factors contributing to the development of cerebral malaria II. Endotoxin. Clin Exp Immunol 1985;61:562-8.
17. Wilairatana P, Looareesuwan S, Vanijanonta S, Charoenlarp P, Wittayalertpanya S. Hepatic metabolism in severe falciparum malaria: caffeine clearance study. Ann Trop Med Parasitol 1994;88:13-9.
18. Kamey WW, Tong MJ. Malabsorption in Plasmodium falciparum malaria. Am J Trop Med Hyg 1972;21:l-5.